228 related articles for article (PubMed ID: 23884408)
1. N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells.
Long PM; Moffett JR; Namboodiri AMA; Viapiano MS; Lawler SE; Jaworski DM
J Biol Chem; 2013 Sep; 288(36):26188-26200. PubMed ID: 23884408
[TBL] [Abstract][Full Text] [Related]
2. Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.
Tsen AR; Long PM; Driscoll HE; Davies MT; Teasdale BA; Penar PL; Pendlebury WW; Spees JL; Lawler SE; Viapiano MS; Jaworski DM
Int J Cancer; 2014 Mar; 134(6):1300-10. PubMed ID: 23996800
[TBL] [Abstract][Full Text] [Related]
3. Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells.
Long PM; Tighe SW; Driscoll HE; Moffett JR; Namboodiri AM; Viapiano MS; Lawler SE; Jaworski DM
PLoS One; 2013; 8(11):e80714. PubMed ID: 24278309
[TBL] [Abstract][Full Text] [Related]
4. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
[TBL] [Abstract][Full Text] [Related]
5. NAAG synthetase deficiency has only low influence on pathogenesis in a Canavan disease mouse model.
Becker I; Wang-Eckhardt L; Eckhardt M
J Inherit Metab Dis; 2024 Mar; 47(2):230-243. PubMed ID: 38011891
[TBL] [Abstract][Full Text] [Related]
6. Regulation of N-acetylaspartate and N-acetylaspartylglutamate biosynthesis by protein kinase activators.
Arun P; Madhavarao CN; Moffett JR; Namboodiri MA
J Neurochem; 2006 Sep; 98(6):2034-42. PubMed ID: 16945114
[TBL] [Abstract][Full Text] [Related]
7. Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells.
Arun P; Moffett JR; Namboodiri AM
Brain Res; 2010 Jun; 1334():25-30. PubMed ID: 20394738
[TBL] [Abstract][Full Text] [Related]
8. Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in Canavan disease?
Baslow MH; Guilfoyle DN
Neurochem Res; 2009 Sep; 34(9):1523-34. PubMed ID: 19319678
[TBL] [Abstract][Full Text] [Related]
9. Labeling of N-acetylaspartate and N-acetylaspartylglutamate in rat neocortex, hippocampus and cerebellum from [1-13C]glucose.
Tyson RL; Sutherland GR
Neurosci Lett; 1998 Jul; 251(3):181-4. PubMed ID: 9726373
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
[TBL] [Abstract][Full Text] [Related]
12. Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain.
Moffett JR; Namboodiri MA; Neale JH
J Histochem Cytochem; 1993 Apr; 41(4):559-70. PubMed ID: 8450195
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells.
Arun P; Madhavarao CN; Moffett JR; Namboodiri AM
J Neurochem; 2008 Aug; 106(4):1669-80. PubMed ID: 18631215
[TBL] [Abstract][Full Text] [Related]
14. N-acetylaspartylglutamate selectively inhibits neuronal responses to N-methyl-D-aspartic acid in vitro.
Burlina AP; Skaper SD; Mazza MR; Ferrari V; Leon A; Burlina AB
J Neurochem; 1994 Sep; 63(3):1174-7. PubMed ID: 8051561
[TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia.
Jessen F; Fingerhut N; Sprinkart AM; Kühn KU; Petrovsky N; Maier W; Schild HH; Block W; Wagner M; Träber F
Schizophr Bull; 2013 Jan; 39(1):197-205. PubMed ID: 21914645
[TBL] [Abstract][Full Text] [Related]
16. Endogenous aspartoacylase expression is responsive to glutamatergic activity in vitro and in vivo.
Francis JS; Strande L; Pu A; Leone P
Glia; 2011 Oct; 59(10):1435-46. PubMed ID: 21608034
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
[TBL] [Abstract][Full Text] [Related]
18. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
[TBL] [Abstract][Full Text] [Related]
19. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.
Baslow MH
J Neurochem; 2000 Aug; 75(2):453-9. PubMed ID: 10899919
[TBL] [Abstract][Full Text] [Related]
20. The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Singhal NK; Huang H; Li S; Clements R; Gadd J; Daniels A; Kooijman EE; Bannerman P; Burns T; Guo F; Pleasure D; Freeman E; Shriver L; McDonough J
Exp Brain Res; 2017 Jan; 235(1):279-292. PubMed ID: 27709268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
